Pot with patents could plant the seeds of future lawsuits
The Conversation: Craig Nard, the Galen J. Roush Professor of Law, wrote about how private companies are securing patents on cannabis-based products and methods of production, even though marijuana remains a Schedule 1 drug—and what it means as the legal marijuana industry grows and medical research on it advances. Republished by Business Insider, Salon, International Business Times and PBS NewsHour.